SG Americas Securities’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,424
| Closed | -$1.2M | – | 3180 |
|
|
2024
Q2 | $1.2M | Buy |
29,424
+24,591
| +509% | +$1.01M | 0.01% | 1127 |
|
|
2024
Q1 | $204K | Sell |
4,833
-19,654
| -80% | -$830K | ﹤0.01% | 1744 |
|
|
2023
Q4 | $1.04M | Buy |
+24,487
| New | +$1.04M | 0.01% | 894 |
|
|
2023
Q3 | – | Sell |
-4,556
| Closed | -$145K | – | 2901 |
|
|
2023
Q2 | $145K | Sell |
4,556
-24,798
| -84% | -$789K | ﹤0.01% | 1679 |
|
|
2023
Q1 | $716K | Buy |
29,354
+14,849
| +102% | +$362K | 0.01% | 1303 |
|
|
2022
Q4 | $457K | Buy |
14,505
+4,271
| +42% | +$135K | 0.01% | 1444 |
|
|
2022
Q3 | $289K | Sell |
10,234
-9,437
| -48% | -$266K | ﹤0.01% | 1799 |
|
|
2022
Q2 | $520K | Buy |
+19,671
| New | +$520K | 0.01% | 1749 |
|
|
2022
Q1 | – | Sell |
-7,913
| Closed | -$257K | – | 3070 |
|
|
2021
Q4 | $257K | Sell |
7,913
-17,155
| -68% | -$557K | ﹤0.01% | 2290 |
|
|
2021
Q3 | $740K | Sell |
25,068
-56,671
| -69% | -$1.67M | ﹤0.01% | 1989 |
|
|
2021
Q2 | $2.09M | Buy |
+81,739
| New | +$2.09M | 0.01% | 993 |
|